que se leu este artigo
array:26 [ "pii" => "S0870255115003170" "issn" => "08702551" "doi" => "10.1016/j.repc.2015.05.009" "estado" => "S300" "fechaPublicacion" => "2016-01-01" "aid" => "738" "copyright" => "Sociedade Portuguesa de Cardiologia" "copyrightAnyo" => "2015" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Port Cardiol. 2016;35:33-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4206 "formatos" => array:3 [ "EPUB" => 199 "HTML" => 3435 "PDF" => 572 ] ] "Traduccion" => array:1 [ "en" => array:19 [ "pii" => "S2174204916000040" "issn" => "21742049" "doi" => "10.1016/j.repce.2016.01.003" "estado" => "S300" "fechaPublicacion" => "2016-01-01" "aid" => "738" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Port Cardiol. 2016;35:33-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3824 "formatos" => array:3 [ "EPUB" => 156 "HTML" => 2968 "PDF" => 700 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Gamma glutamyltransferase, inflammation and cardiovascular risk factors in isolated coronary artery ectasia" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "pt" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "33" "paginaFinal" => "39" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Gama glutamiltransferase, inflamação e fatores de risco cardiovasculares na ectasia isolada da artéria coronária" ] ] "contieneResumen" => array:2 [ "en" => true "pt" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1042 "Ancho" => 1455 "Tamanyo" => 91238 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Comparison of GGT and hs-CRP tertiles of patients with coronary artery ectasia (CAE) and of controls with normal coronary arteries. p values were calculated by the chi-square test for independence. GGT: gamma glutamyl transferase; hs-CRP: high-sensitivity C-reactive protein.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Abdullah Dogan, Akif Arslan, Habil Yucel, Fatih Aksoy, Atilla Icli, Mehmet Ozaydin, Ercan Varol, Dogan Erdogan" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Abdullah" "apellidos" => "Dogan" ] 1 => array:2 [ "nombre" => "Akif" "apellidos" => "Arslan" ] 2 => array:2 [ "nombre" => "Habil" "apellidos" => "Yucel" ] 3 => array:2 [ "nombre" => "Fatih" "apellidos" => "Aksoy" ] 4 => array:2 [ "nombre" => "Atilla" "apellidos" => "Icli" ] 5 => array:2 [ "nombre" => "Mehmet" "apellidos" => "Ozaydin" ] 6 => array:2 [ "nombre" => "Ercan" "apellidos" => "Varol" ] 7 => array:2 [ "nombre" => "Dogan" "apellidos" => "Erdogan" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0870255115003170" "doi" => "10.1016/j.repc.2015.05.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255115003170?idApp=UINPBA00004E" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204916000040?idApp=UINPBA00004E" "url" => "/21742049/0000003500000001/v2_201703220342/S2174204916000040/v2_201703220342/en/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S0870255115003145" "issn" => "08702551" "doi" => "10.1016/j.repc.2015.09.006" "estado" => "S300" "fechaPublicacion" => "2016-01-01" "aid" => "735" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "ssu" "cita" => "Rev Port Cardiol. 2016;35:41-57" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 11362 "formatos" => array:3 [ "EPUB" => 179 "HTML" => 10068 "PDF" => 1115 ] ] "pt" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Artigo de revisão</span>" "titulo" => "Estatinas e stresse oxidativo na insuficiência cardíaca crónica" "tienePdf" => "pt" "tieneTextoCompleto" => "pt" "tieneResumen" => array:2 [ 0 => "pt" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "41" "paginaFinal" => "57" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Statins and oxidative stress in chronic heart failure" ] ] "contieneResumen" => array:2 [ "pt" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "pt" => true ] "contienePdf" => array:1 [ "pt" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0025" "etiqueta" => "Figura 5" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr5.jpeg" "Alto" => 1764 "Ancho" => 3250 "Tamanyo" => 333397 ] ] "descripcion" => array:1 [ "pt" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Ação das estatinas na Nox2 em células endoteliais.</p> <p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">A Nox2 é constituída por vários componentes como as subunidades membranares p22phox e Nox2 (gp91phox), e por subunidades citosólicas como a p47phox, a p67phox, a p40phox e a GTP‐Rac. A ativação da Nox requer a ativação e translocação para a membrana da proteína Rac e da p47phox, p67phox e p40phox. A ativação da Rac está dependente da isoprenilação desta proteína pelo GGPF. A inibição da formação deste último pelas estatinas, previne a ativação da Rac e, consequentemente, da Nox2. Outro mecanismo pelo qual as estatinas inibem a Nox2 parece estar associado a alterações da fosforilação da PKC e da translocação membranar da p47phox e é, em parte, mediado pela adiponectina que inibe a translocação da p47phox.</p> <p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">ADP – difosfato de adenosina; ARNm – ácido ribonucleico mensageiro; FPF – farnesilpirofosfato; GGPF – geranilgeranilpirofosfato; GTP – trifosfato de guanosina; HMG‐CoA – hidroximetilglutaril Coenzima A; Nox – NADPH oxídase; O<span class="elsevierStyleInf">2</span> – oxigénio; O<span class="elsevierStyleInf">2</span><span class="elsevierStyleSup">•−</span> – superóxido; PKC – cínase C de proteínas.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sónia Costa, Marta Reina‐Couto, António Albino‐Teixeira, Teresa Sousa" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Sónia" "apellidos" => "Costa" ] 1 => array:2 [ "nombre" => "Marta" "apellidos" => "Reina‐Couto" ] 2 => array:2 [ "nombre" => "António" "apellidos" => "Albino‐Teixeira" ] 3 => array:2 [ "nombre" => "Teresa" "apellidos" => "Sousa" ] ] ] ] ] "idiomaDefecto" => "pt" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2174204915003013" "doi" => "10.1016/j.repce.2015.12.016" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204915003013?idApp=UINPBA00004E" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255115003145?idApp=UINPBA00004E" "url" => "/08702551/0000003500000001/v2_201601300110/S0870255115003145/v2_201601300110/pt/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S0870255115003200" "issn" => "08702551" "doi" => "10.1016/j.repc.2015.07.010" "estado" => "S300" "fechaPublicacion" => "2016-01-01" "aid" => "741" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Port Cardiol. 2016;35:25-31" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3036 "formatos" => array:3 [ "EPUB" => 206 "HTML" => 2259 "PDF" => 571 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Validity of the updated GRACE risk predictor (version 2.0) in patients with non-ST-elevation acute coronary syndrome" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "pt" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "25" "paginaFinal" => "31" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Validade da atualização do preditor de risco GRACE (versão 2,0) em doentes com síndrome coronária aguda sem elevação do segmento ST" ] ] "contieneResumen" => array:2 [ "en" => true "pt" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1268 "Ancho" => 2592 "Tamanyo" => 177964 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Receiver operating characteristic curves for in-hospital and 1-year mortality. AUC: area under the curve; CI: confidence interval; SE: standard error.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sukru Akyuz, Selcuk Yazici, Emrah Bozbeyoglu, Tolga Onuk, Ozlem Yildirimturk, Denizhan Karacimen, Mert Ilker Hayiroglu, Guney Erdogan, Abdullah Orcun Oner, Ali Nazmi Calik, Metin Cagdas, Nese Cam" "autores" => array:12 [ 0 => array:2 [ "nombre" => "Sukru" "apellidos" => "Akyuz" ] 1 => array:2 [ "nombre" => "Selcuk" "apellidos" => "Yazici" ] 2 => array:2 [ "nombre" => "Emrah" "apellidos" => "Bozbeyoglu" ] 3 => array:2 [ "nombre" => "Tolga" "apellidos" => "Onuk" ] 4 => array:2 [ "nombre" => "Ozlem" "apellidos" => "Yildirimturk" ] 5 => array:2 [ "nombre" => "Denizhan" "apellidos" => "Karacimen" ] 6 => array:2 [ "nombre" => "Mert Ilker" "apellidos" => "Hayiroglu" ] 7 => array:2 [ "nombre" => "Guney" "apellidos" => "Erdogan" ] 8 => array:2 [ "nombre" => "Abdullah Orcun" "apellidos" => "Oner" ] 9 => array:2 [ "nombre" => "Ali Nazmi" "apellidos" => "Calik" ] 10 => array:2 [ "nombre" => "Metin" "apellidos" => "Cagdas" ] 11 => array:2 [ "nombre" => "Nese" "apellidos" => "Cam" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2174204916000052" "doi" => "10.1016/j.repce.2016.01.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204916000052?idApp=UINPBA00004E" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255115003200?idApp=UINPBA00004E" "url" => "/08702551/0000003500000001/v2_201601300110/S0870255115003200/v2_201601300110/en/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S0870255116301809" "issn" => "08702551" "doi" => "10.1016/j.repc.2016.04.011" "estado" => "S300" "fechaPublicacion" => "2016-10-01" "aid" => "871" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Rev Port Cardiol. 2016;35:553-4" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2285 "formatos" => array:3 [ "EPUB" => 207 "HTML" => 1602 "PDF" => 476 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "The relation between inflammation and coronary artery ectasia" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "553" "paginaFinal" => "554" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "A relação entre a inflamação e a ectasia arterial coronária" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Sevket Balta, Mustafa Demir, Cengiz Ozturk, Turgay Celik" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Sevket" "apellidos" => "Balta" ] 1 => array:2 [ "nombre" => "Mustafa" "apellidos" => "Demir" ] 2 => array:2 [ "nombre" => "Cengiz" "apellidos" => "Ozturk" ] 3 => array:2 [ "nombre" => "Turgay" "apellidos" => "Celik" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2174204916301635" "doi" => "10.1016/j.repce.2016.04.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204916301635?idApp=UINPBA00004E" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255116301809?idApp=UINPBA00004E" "url" => "/08702551/0000003500000010/v1_201609231322/S0870255116301809/v1_201609231322/en/main.assets" ] ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "Gamma glutamyltransferase, inflammation and cardiovascular risk factors in isolated coronary artery ectasia" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "33" "paginaFinal" => "39" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Abdullah Dogan, Akif Arslan, Habil Yucel, Fatih Aksoy, Atilla Icli, Mehmet Ozaydin, Ercan Varol, Dogan Erdogan" "autores" => array:8 [ 0 => array:2 [ "nombre" => "Abdullah" "apellidos" => "Dogan" ] 1 => array:4 [ "nombre" => "Akif" "apellidos" => "Arslan" "email" => array:1 [ 0 => "dr.akifarslan@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 2 => array:2 [ "nombre" => "Habil" "apellidos" => "Yucel" ] 3 => array:2 [ "nombre" => "Fatih" "apellidos" => "Aksoy" ] 4 => array:2 [ "nombre" => "Atilla" "apellidos" => "Icli" ] 5 => array:2 [ "nombre" => "Mehmet" "apellidos" => "Ozaydin" ] 6 => array:2 [ "nombre" => "Ercan" "apellidos" => "Varol" ] 7 => array:2 [ "nombre" => "Dogan" "apellidos" => "Erdogan" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Cardiology Department, Medical School, Suleyman Demirel University, Isparta, Turkey" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Gama glutamiltransferase, inflamação e fatores de risco cardiovasculares na ectasia isolada da artéria coronária" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1731 "Ancho" => 2418 "Tamanyo" => 124103 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Comparison of GGT and hs-CRP tertiles of patients with coronary artery ectasia (CAE) and of controls with normal coronary arteries. p values were calculated by the chi-square test for independence. GGT: gamma glutamyl transferase; hs-CRP: high-sensitivity C-reactive protein.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Coronary artery ectasia (CAE) is characterized by an abnormal dilatation of the coronary arteries.<a class="elsevierStyleCrossRefs" href="#bib0165"><span class="elsevierStyleSup">1–3</span></a> More than half of cases of CAE are due to atherosclerosis, and it has thus been considered a variant of atherosclerotic coronary artery disease (CAD).<a class="elsevierStyleCrossRefs" href="#bib0165"><span class="elsevierStyleSup">1–3</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">It has been shown that inflammation is one of the causes of atherosclerosis.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">4</span></a> Similarly, previous studies have shown a link between C-reactive protein (CRP) and CAE.<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">5,6</span></a> However, these studies were relatively small. On the other hand, there is a variety of data on the association of major risk factors for atherosclerosis with CAE.<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">2,3,7–11</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Gamma glutamyltransferase (GGT) catalyzes glutathione, a major non-protein antioxidant in the cell.<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">12</span></a> It plays a role in oxidation of low-density lipoprotein (LDL) cholesterol and in the pathogenesis of atherosclerosis.<a class="elsevierStyleCrossRefs" href="#bib0225"><span class="elsevierStyleSup">13,14</span></a> Epidemiologic studies have reported that serum GGT level has predictive value for cardiovascular disease and mortality in the general population.<a class="elsevierStyleCrossRefs" href="#bib0235"><span class="elsevierStyleSup">15–17</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">There have been two studies evaluating GGT levels in CAE patients. They showed that GGT levels were increased in patients with CAE,<a class="elsevierStyleCrossRefs" href="#bib0250"><span class="elsevierStyleSup">18,19</span></a> but these studies were small. Therefore, we aimed to investigate serum GGT and CRP levels in addition to major risk factors for atherosclerosis in a larger population of patients with isolated CAE.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Patients</span><p id="par0025" class="elsevierStylePara elsevierViewall">Between January 2007 and December 2012, 427 (4.1%) patients with CAE were selected from 10<span class="elsevierStyleHsp" style=""></span>505 patients who underwent elective diagnostic coronary angiography in our center. After application of the exclusion criteria, the remaining 167 (1.6%) isolated CAE patients were designated the CAE group. During the same period, 150 age- and gender-matched controls with normal coronary arteries were consecutively selected. The indication for coronary angiography was the presence of typical angina pectoris or significant myocardial ischemia in noninvasive stress tests.</p><p id="par0030" class="elsevierStylePara elsevierViewall">Exclusion criteria were as follows: acute coronary syndromes, history of alcohol consumption, high alanine and/or aspartate transaminase levels, presence of concomitant stenotic lesion (>25% stenosis), significant left ventricular hypertrophy (septal thickness ≥13 mm), hematologic disorders, acute or chronic infectious disease, hepatitis or previously known inflammatory/autoimmune disorders, renal dysfunction (serum creatinine ≥177 mmol/l), documented cancer, use of steroids, and significant valvular heart disease (moderate to severe for stenotic lesions or grade ≥2 for valvular regurgitation).</p><p id="par0035" class="elsevierStylePara elsevierViewall">A detailed medical history and history of cardiovascular risk factors such as diabetes, hypertension and smoking were obtained from the study population. For each patient, body mass index (BMI) was calculated by the formula of weight (kg) divided by height (m)<span class="elsevierStyleSup">2</span>. BMI was categorized as normal (≤25 kg/m<span class="elsevierStyleSup">2</span>), overweight (25–30 kg/m<span class="elsevierStyleSup">2</span>) or obesity (>30 kg/m<span class="elsevierStyleSup">2</span>). Hypertension was considered to be present if systolic blood pressure was ≥140 mmHg or diastolic blood pressure was ≥90 mmHg or both, or if the individual was taking antihypertensive medication. Diabetes was defined as the use of antidiabetic therapy or a fasting plasma glucose level of ≥7 mmol/l (≥126 mg/dl) in at least two measurements. Family history of CAD was diagnosed if patients had a first-degree male relative <55 years of age or female relative <65 years of age with CAD. Patients who smoked before hospitalization were classified as smokers. Hyperlipidemia was defined as LDL cholesterol ≥3.4 mmol/l (≥130 mg/dl), triglycerides ≥2.26 mmol/l (≥200 mg/dl) or use of lipid-lowering drugs.</p><p id="par0040" class="elsevierStylePara elsevierViewall">All patients gave their informed consent for participation in the study, which was approved by the local ethics committee.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Blood sampling and assays</span><p id="par0045" class="elsevierStylePara elsevierViewall">Blood samples were drawn after a fasting period of 12 hours. Serum glucose, creatinine and lipid profile were determined by standard methods. Whole blood counts were made in a blood sample collected in dipotassium EDTA tubes with an automatic blood counter (Beckman Coulter Inc., CA, USA). Serum GGT levels were measured by the enzymatic calorimetric method using commercially available test kits with an AU640 auto-analyzer (Olympus, Japan). Normal values were defined as 0–50 U/l in our laboratory. In addition, other biochemical tests were performed using original kits with the Olympus autoanalyzer. Serum hs-CRP was measured by nephelometry using commercially available kits in accordance with the manufacturer's instructions (Beckman Coulter Array 360, Brea, CA, USA).</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Angiographic evaluation</span><p id="par0050" class="elsevierStylePara elsevierViewall">Using the Judkins technique, coronary angiography was performed with contrast agents without intracoronary nitroglycerin. Arteriograms were obtained in both right and left anterior oblique projection with caudal and cranial angulation for the left and right coronary system. Additional views were also obtained in patients with inadequate visualization. Images were recorded in digital format and stored for later analysis. Right anterior oblique view was used to evaluate ectasia for the left coronary system and left anterior oblique view for the right coronary artery. Evaluations were performed visually by two experienced angiographers blinded to each other's findings. Vessel diameter was calculated quantitatively in the event of disagreement concerning CAE. Each major coronary artery was subdivided into proximal, mid, and distal segments.</p><p id="par0055" class="elsevierStylePara elsevierViewall">Coronary ectasia was defined as dilation exceeding 1.5 times the normal diameter of normal adjacent segments.<a class="elsevierStyleCrossRefs" href="#bib0165"><span class="elsevierStyleSup">1–3</span></a> If no normal adjacent segment could be identified, the mean diameter of the corresponding segment in the control group was taken as the normal value. If the coronary arteries had a normal appearance or no atherosclerotic plaques with ≥25% stenosis, they were regarded as normal. Patients with concomitant obstructive and ectatic lesions were not included in the study. CAE was defined as focal when involving one segment and as diffuse when involving two or more segments in a major coronary artery, and as severe when diffuse (≥2 segments) in ≥2 vessels.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Statistical analysis</span><p id="par0060" class="elsevierStylePara elsevierViewall">Continuous variables were presented as mean ± standard deviation or median (interquartile range [IQR] of the 25th–75th percentiles of GGT and hs-CRP levels) and categorical variables as number (%). Comparisons between the groups were performed with the Student's t test, the Mann-Whitney U test and chi-square test or Fisher's exact test as appropriate. Gender-specific GGT tertiles were calculated in both groups, with GGT cut points of 18 and 24 U/l in men and 15 and 23 U/l in women delineating low, mid and top tertiles. Similarly, hs-CRP was categorized into low, mid and top tertiles (cut points of 1.53 and 2.56 mg/l). After univariate analyses had been performed for CAE, binary logistic regression analysis was performed to identify independent variables associated with the presence of CAE. Confounders which had significance at the p≤0.15 level were entered into the regression analysis. They were hypertension, diabetes, obesity, triglycerides, uric acid, GGT, hs-CRP and platelet count. Odds ratios (OR) and 95% confidence intervals were calculated. The correlation between GGT and CRP levels was evaluated by Pearson correlation analysis. A p value of <0.05 was considered significant. All analyses were performed using SPSS 12.0 (SPSS Inc., Chicago, Illinois, USA).</p></span></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Results</span><p id="par0065" class="elsevierStylePara elsevierViewall">The demographic and clinical characteristics of the CAE and control groups are presented in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>. Hypertension and obesity were slightly more prevalent in CAE patients compared with controls, whereas the prevalence of diabetes was slightly lower. Other parameters were comparable in the two groups.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0070" class="elsevierStylePara elsevierViewall">Coronary ectasia was located most frequently in the left anterior descending artery (62%), followed by the right coronary artery (59%) and circumflex artery (29%). Diffuse ectasia was seen in 91 patients (55%) and multivessel ectasia in 67 (40%).</p><p id="par0075" class="elsevierStylePara elsevierViewall">Laboratory variables of the study groups are shown in <a class="elsevierStyleCrossRef" href="#tbl0020">Table 2</a>. Triglyceride level and platelet count were higher in the CAE group than in the control group. Similarly, CAE patients had slightly higher uric acid levels (329.2±75.6 vs. 311.7±72.7 μmol/l, p=0.06). Other parameters were similar in both groups.</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia><p id="par0090" class="elsevierStylePara elsevierViewall">Median GGT level was higher in CAE patients than in controls (22 [IQR: 17–42] vs. 16 [IQR: 13–21] U/l, p=0.001, <a class="elsevierStyleCrossRef" href="#tbl0020">Table 2</a>, <a class="elsevierStyleCrossRef" href="#fig0005">Figure 1</a>A). Similarly, hs-CRP levels were higher in CAE patients than in controls (2.9 [IQR: 1.9–3.6] vs. 1.4 [IQR: 1.1–1.8] mg/l, p=0.001, <a class="elsevierStyleCrossRef" href="#fig0005">Figure 1</a>B). The percentages of patients in the top tertile of GGT and hs-CRP were higher in CAE patients than in controls (p for each trend=0.001, <a class="elsevierStyleCrossRef" href="#fig0010">Figure 2</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0095" class="elsevierStylePara elsevierViewall">In logistic regression analysis, the presence of CAE was independently and positively associated with GGT levels (OR: 1.08, 95% CI: 1.03–1.12, p=0.001), hs-CRP levels (OR: 3.1, 95% CI: 2.10–4.59, p=0.001) and obesity (OR: 2.84, 95% CI: 1.07–7.56, p=0.038), but negatively with diabetes (OR: 0.44, 95% CI: 0.20–0.95, p=0.036).</p><p id="par0100" class="elsevierStylePara elsevierViewall">In addition, GGT and hs-CRP levels were significantly higher in diffuse and multivessel ectasia subgroups than in focal and single-vessel ectasia subgroups (<a class="elsevierStyleCrossRef" href="#tbl0030">Table 3</a>). There was a moderate correlation between GGT and hs-CRP levels (r=0.50, p=0.001).</p><elsevierMultimedia ident="tbl0030"></elsevierMultimedia></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Discussion</span><p id="par0105" class="elsevierStylePara elsevierViewall">In this study, obesity and hypertension were slightly more prevalent but diabetes less prevalent in CAE patients than in controls. Similarly, serum GGT and hs-CRP levels were higher in patients with CAE. The presence of CAE was positively associated with obesity and GGT and hs-CRP levels but inversely with diabetes. Also, the severity of CAE was linked with GGT and hs-CRP levels.</p><p id="par0110" class="elsevierStylePara elsevierViewall">The prevalence of CAE varies from 1% to 5% in angiographic series.<a class="elsevierStyleCrossRefs" href="#bib0165"><span class="elsevierStyleSup">1–3</span></a> Although CAE is largely attributed to atherosclerosis, its causative and pathologic mechanisms are not clearly understood.<a class="elsevierStyleCrossRefs" href="#bib0165"><span class="elsevierStyleSup">1–3</span></a> It may appear a relatively innocent clinical entity; however, it can cause cardiac events such as stable or unstable angina pectoris, myocardial infarction and cardiac death.<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">7,9,20</span></a></p><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Cardiovascular risk factors and coronary artery ectasia</span><p id="par0115" class="elsevierStylePara elsevierViewall">Previous small studies have reported different frequencies of major risk factors for atherosclerosis in isolated CAE patients.<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">2,3,7–11</span></a> In our study, there was a predominance of male gender (58%) in CAE patients, as in previous studies.<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">2,8,11,18,21</span></a> The proportion reaches 85% in some studies.<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">7,9</span></a></p><p id="par0120" class="elsevierStylePara elsevierViewall">Among risk factors, hypertension and obesity were slightly more prevalent in isolated CAE patients in the present study, whereas the rate of diabetes was lower in CAE patients. Other factors were at similar percentages. Only one study has shown a higher frequency of hypertension in CAE patients,<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">11</span></a> in contrast to other studies.<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">2,3,7–10,18,19</span></a> Similarly, hyperlipidemia has been reported to be more common in CAE patients in one study<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">9</span></a> but not in others.<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">2,3,7,8,10,11,18,19</span></a> Both high<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">8</span></a> and low<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">7,9</span></a> prevalences of smoking have also been documented in patients with CAE. We consider that these conflicting results may be mainly due to the selection of the control group from patients undergoing coronary angiography, and the small size of the studies. We constituted the control group from patients with normal coronary arteries, whereas some studies selected patients with CAD as the control group.<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">7,9</span></a></p><p id="par0125" class="elsevierStylePara elsevierViewall">Interestingly, previous studies<a class="elsevierStyleCrossRefs" href="#bib0200"><span class="elsevierStyleSup">8,10</span></a> reported an inverse association between CAE and diabetes, as in our study, in which diabetes independently decreased the likelihood of CAE (OR: 0.44). However, this inverse association was not seen in several other studies.<a class="elsevierStyleCrossRefs" href="#bib0175"><span class="elsevierStyleSup">3,4,7,9,11,18</span></a> There are two potential explanations for this association: in diabetic patients, compared with non-diabetic patients, negative arterial remodeling is seen more frequently in the coronary arteries during the progression of atherosclerotic plaques<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">22</span></a>; and consequently obstructive CAD can be found more commonly in diabetic patients.<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">23</span></a></p><p id="par0130" class="elsevierStylePara elsevierViewall">We found that obesity independently increased the likelihood of CAE (OR: 2.84, p=0.04). Such an association was not present in previous studies.<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">2,3,7–11,18,21</span></a> We think that this finding may be the result of compensatory enlargement due to increased body weight, because we did not routinely measure the diameters of the ectatic vessels and did not index them to body surface area.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Gamma glutamyltransferase, inflammation and coronary artery ectasia</span><p id="par0135" class="elsevierStylePara elsevierViewall">In humans, GGT is responsible for extracellular catabolism of glutathione, an antioxidant.<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">12</span></a> There is evidence that GGT triggers oxidative stress within atherosclerotic plaque and promotes the atherosclerotic process by means of LDL oxidation.<a class="elsevierStyleCrossRefs" href="#bib0220"><span class="elsevierStyleSup">12–14</span></a> This finding has been supported by large epidemiologic studies<a class="elsevierStyleCrossRefs" href="#bib0235"><span class="elsevierStyleSup">15,16</span></a> in which GGT level is independently associated with cardiovascular disease and mortality. Furthermore, it is an independent predictor of fatal and non-fatal cardiac events in patients with documented CAD.<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">22</span></a></p><p id="par0140" class="elsevierStylePara elsevierViewall">Two recent studies have reported that GGT levels are increased in patients with isolated CAE compared to controls with normal coronary arteries, but are not associated with the severity of CAE.<a class="elsevierStyleCrossRefs" href="#bib0250"><span class="elsevierStyleSup">18,19</span></a> Their sample size was small, including only 88 and 45 CAE patients. In our larger study, CAE patients had a higher level of GGT compared with controls. Moreover, GGT was independently associated with the presence of CAE as well as with the severity of CAE. We think that GGT may have a prognostic value for CAE, as also reported for atherosclerotic CAD.<a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">24</span></a></p><p id="par0145" class="elsevierStylePara elsevierViewall">Inflammation plays a key role in the atherosclerotic process and CRP can predict future cardiovascular events in men and women at risk.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">4</span></a> hs-CRP has been documented to be elevated in patients with CAE in some studies<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">5,6</span></a> but not in others.<a class="elsevierStyleCrossRefs" href="#bib0285"><span class="elsevierStyleSup">25,26</span></a> However, these studies had small patient populations. In the present study, hs-CRP levels were higher in CAE patients than controls, and independently associated with the presence of CAE.</p><p id="par0150" class="elsevierStylePara elsevierViewall">Previous studies showed an association of GGT with CRP.<a class="elsevierStyleCrossRefs" href="#bib0225"><span class="elsevierStyleSup">13,27,28</span></a> GGT can act as a proinflammatory protein in atherogenesis<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">27</span></a> and is associated with atherosclerotic risk factors including obesity, dyslipidemia, metabolic syndrome, hypertension and diabetes.<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">16,17,28</span></a> There was a moderate link between GGT and hs-CRP in our study. This evidence suggests that GGT and CRP may reflect chronic occult inflammation in CAE patients.</p><p id="par0155" class="elsevierStylePara elsevierViewall">In addition, some small studies reported similar platelet counts in CAE and control groups,<a class="elsevierStyleCrossRefs" href="#bib0305"><span class="elsevierStyleSup">29–31</span></a> but in contrast, one large study reported significantly lower platelet counts in CAE patients than in controls.<a class="elsevierStyleCrossRef" href="#bib0320"><span class="elsevierStyleSup">32</span></a> Similarly, in our larger study, platelet count was lower in the CAE group. We consider that these conflicting results may be mainly due to the small size of the studies.</p></span></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Limitations</span><p id="par0160" class="elsevierStylePara elsevierViewall">Our study has some limitations. Firstly, a major limitation is that we did not make prognostic assessments based on GGT levels, because of the small number of major cardiac events: two myocardial infarctions and three presentations with recurrent angina. Secondly, the prevalence of obesity was slightly higher in CAE patients, although mean BMI was similar in the two groups. Hepatic steatosis secondary to obesity may have contributed to higher GGT levels in CAE patients, but we did not evaluate this in each patient. Finally, our findings reflect the situation of patients with chest pain undergoing coronary angiography, but not that of the general population.</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Conclusion</span><p id="par0165" class="elsevierStylePara elsevierViewall">Our findings show that the presence of CAE can be independently and positively associated with serum GGT and hs-CRP levels but negatively with diabetes. GGT and hs-CRP may also reflect the severity of CAE. Hence, their measurement may be useful in the evaluation of patients with CAE, as documented in patients with CAD. However, these findings should be supported by further studies.</p></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Ethical disclosures</span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">Protection of human and animal subjects</span><p id="par0170" class="elsevierStylePara elsevierViewall">The authors declare that the procedures followed were in accordance with the regulations of the relevant clinical research ethics committee and with those of the Code of Ethics of the World Medical Association (Declaration of Helsinki).</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Confidentiality of data</span><p id="par0175" class="elsevierStylePara elsevierViewall">The authors declare that they have followed the protocols of their work center on the publication of patient data.</p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">Right to privacy and informed consent</span><p id="par0180" class="elsevierStylePara elsevierViewall">The authors have obtained the written informed consent of the patients or subjects mentioned in the article. The corresponding author is in possession of this document.</p></span></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0145">Conflicts of interest</span><p id="par0185" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:13 [ 0 => array:3 [ "identificador" => "xres600705" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction and Objective" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec614907" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres600704" "titulo" => "Resumo" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Introdução e objetivos" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusão" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec614908" "titulo" => "Palavras-chave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Methods" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Patients" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Blood sampling and assays" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Angiographic evaluation" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Statistical analysis" ] ] ] 6 => array:2 [ "identificador" => "sec0035" "titulo" => "Results" ] 7 => array:3 [ "identificador" => "sec0040" "titulo" => "Discussion" "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0045" "titulo" => "Cardiovascular risk factors and coronary artery ectasia" ] 1 => array:2 [ "identificador" => "sec0050" "titulo" => "Gamma glutamyltransferase, inflammation and coronary artery ectasia" ] ] ] 8 => array:2 [ "identificador" => "sec0055" "titulo" => "Limitations" ] 9 => array:2 [ "identificador" => "sec0060" "titulo" => "Conclusion" ] 10 => array:3 [ "identificador" => "sec0065" "titulo" => "Ethical disclosures" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0070" "titulo" => "Protection of human and animal subjects" ] 1 => array:2 [ "identificador" => "sec0075" "titulo" => "Confidentiality of data" ] 2 => array:2 [ "identificador" => "sec0080" "titulo" => "Right to privacy and informed consent" ] ] ] 11 => array:2 [ "identificador" => "sec0085" "titulo" => "Conflicts of interest" ] 12 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2015-03-15" "fechaAceptado" => "2015-05-11" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec614907" "palabras" => array:4 [ 0 => "Coronary ectasia" 1 => "Risk factors" 2 => "Inflammation" 3 => "Gamma glutamyltransferase" ] ] ] "pt" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palavras-chave" "identificador" => "xpalclavsec614908" "palabras" => array:4 [ 0 => "Ectasia coronária" 1 => "Fatores de risco" 2 => "Inflamação" 3 => "Glutamiltransferase" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction and Objective</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">There are conflicting data on the prevalence of cardiovascular risk factors in coronary artery ectasia (CAE). It is unclear whether CAE is associated with high-sensitivity C-reactive protein (hs-CRP) and gamma glutamyltransferase (GGT). We therefore investigated major cardiovascular risk factors, serum GGT and hs-CRP levels in a large population of patients with CAE.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A total of 167 patients with isolated CAE and 150 controls with normal coronary arteries were selected from 10<span class="elsevierStyleHsp" style=""></span>505 patients undergoing coronary angiography. Serum GGT and hs-CRP levels were evaluated in addition to cardiovascular risk factors including family history, obesity, smoking, diabetes, hypertension and hyperlipidemia.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Hypertension and obesity were slightly more prevalent in CAE patients than in controls, whereas diabetes was slightly less frequent in CAE patients. Other risk factors were similar. Serum GGT (22 [17–42] vs. 16 [13–21] U/l, p=0.001) and hs-CRP (2.9 [1.9–3.6] vs. 1.4 [1.1–1.8] mg/l, p=0.001) levels were higher in CAE patients than in controls. The presence of CAE was independently associated with diabetes (OR: 0.44, 95% CI: 0.20–0.95, p=0.04), obesity (OR: 2.84, 95% CI: 1.07–7.56, p=0.04), GGT (OR: 1.08, 95% CI: 1.03–1.12, p=0.001) and hs-CRP levels (OR: 3.1, 95% CI: 2.1–4.6, p=0.001). In addition, GGT and hs-CRP levels were higher in diffuse and multivessel ectasia subgroups than focal and single-vessel ectasia subgroups (each p<0.05).</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Our findings show that CAE can be independently and positively associated with obesity, GGT and hs-CRP levels, but inversely with diabetes. Moreover, its severity may be related to GGT and hs-CRP levels.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Introduction and Objective" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] "pt" => array:3 [ "titulo" => "Resumo" "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Introdução e objetivos</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Existem dados contraditórios relativamente à prevalência dos fatores de risco cardiovascular na ectasia da artéria coronária (EAC). Não é claro se a EAC possa estar associada à proteína C reativa de alta-sensibilidade (PCR-as) e à gama glutamiltransferase (gama-GT). Assim examinámos fatores de risco cardiovascular <span class="elsevierStyleItalic">major</span>, a gama-GT sérica e os níveis de PCR-as numa população mais alargada de doentes com EAC.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Métodos</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Foram selecionados um total de 167 doentes com EAC isolada e 150 casos-controlo com artérias coronárias normais dos 10 505 doentes submetidos a angiografia coronária. A gama-GT sérica e os níveis de PCR-as foram avaliados para além dos fatores de risco cardiovascular incluindo a história familiar, obesidade, tabagismo, diabetes, hipertensão e hiperlipidemia.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">A hipertensão e a obesidade foram ligeiramente mais prevalentes nos doentes com EAC do que nos casos-controlo enquanto a diabetes foi menos frequente nos doentes com EAC. Os outros fatores de risco foram semelhantes. Os níveis de gama-GT sérica [22 (17-42) <span class="elsevierStyleItalic">versus</span> 16 (13-21) U/L, p =0,001] e de PCR-as [2,9 (1,9-3,6) <span class="elsevierStyleItalic">versus</span> 1,4 (1,1-1,8) mg/L, p =0,001] foram superiores nos doentes com EAC do que nos casos-controlo. A presença de EAC foi independentemente associada à diabetes (OR: 0,44, IC 95%: 0,20-0,95, p =0,04), obesidade (OR: 2,84, IC 95%: 1,07-7,56, p =0,04), gama-GT (OR:1,08, IC 95%: 1,03-1,12, p =0,001) e níveis de PCR-as (OR:3,1, IC 95%: 2,1-4,6, p =0,001). Além disso, os níveis de GGT e de PCR-as foram superiores nos subgrupos de ectasia difusa e mutivasos do que nos subgrupos de ectasia focal e de um vaso (cada p < 0,05).</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusão</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">As nossas conclusões mostram que a EAC pode ser certamente associada à obesidade, aos níveis de gama-GT e de PCR-as, mas de modo inverso à diabetes. Além disso a sua gravidade pode estar associada aos níveis de gama-GT e de PCR-as.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Introdução e objetivos" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusão" ] ] ] ] "multimedia" => array:5 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1406 "Ancho" => 2995 "Tamanyo" => 102114 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Box plots showing serum gamma-glutamyltransferase (GGT) (A) and high-sensitivity C-reactive protein (hs-CRP) (B) levels in controls and in patients with isolated coronary artery ectasia (CAE).</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1731 "Ancho" => 2418 "Tamanyo" => 124103 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Comparison of GGT and hs-CRP tertiles of patients with coronary artery ectasia (CAE) and of controls with normal coronary arteries. p values were calculated by the chi-square test for independence. GGT: gamma glutamyl transferase; hs-CRP: high-sensitivity C-reactive protein.</p>" ] ] 2 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">ACEIs: angiotensin-converting enzyme inhibitors; ARBs: angiotensin receptor blockers; BMI: body mass index; CAD: coronary artery disease; CAE: coronary artery ectasia; DBP: diastolic blood pressure; SBP: systolic blood pressure.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Variables \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">CAE group (n=167) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Control group (n=150) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">p \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Age, years</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">58.7±8.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">59.7±7.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.38 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Male/female</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">102/65 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">84/66 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.42 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">BMI (kg/m</span><span class="elsevierStyleSup"><span class="elsevierStyleItalic">2</span></span><span class="elsevierStyleItalic">)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">27.1±2.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">26.9±2.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.50 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Smoking</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">64 (38%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">70 (47%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.16 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Hypertension</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">124 (74%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">96 (64%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.052 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Diabetes</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">31 (19%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">41 (27%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.08 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Family history of CAD</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">30 (18%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">22 (15%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.45 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Dyslipidemia</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">58 (35%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">46 (31%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.47 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Obesity</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">27 (16%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13 (9%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.06 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">SBP (mmHg)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">128±16 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">127±14 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.55 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">DBP (mmHg)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">77±9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">76±8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.30 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="4" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="4" align="left" valign="top"><span class="elsevierStyleItalic">Medications</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Aspirin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">162 (97%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">148 (99%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.45 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Beta-blockers \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">142 (85%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">118 (79%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.17 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Statins \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">50 (30%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">39 (26%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.51 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>ACEIs or ARBs \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">80 (48%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">39 (56%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.18 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Calcium antagonists \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">23 (14%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">26 (17%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.44 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab982783.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Demographic and clinical characteristics of the study population.</p>" ] ] 3 => array:7 [ "identificador" => "tbl0020" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:3 [ "leyenda" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">ALT: alanine transaminase; AST: aspartate transaminase; GGT: gamma glutamyltransferase; hs-CRP: high-sensitivity C-reactive protein; WBC: white blood count.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">CAE group (n=167) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Control group (n=150) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">p \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Blood glucose (mmol/l) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6.10±1.51 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6.28±2.66 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.45 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">AST (U/l) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">22.6±7.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">23.6±8.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.27 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">ALT (U/l) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20.2±8.8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">21.1±9.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.39 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">GGT (U/l)<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">22 (17–42) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">16 (13–21) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">hs-CRP (mg/l)<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.9 (1.9–3.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1.4 (1.1–1.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Creatinine (mmol/l) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">90.71±17.05 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">94.18±20.73 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.80 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Total cholesterol (mmol/l) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.78±0.89 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.81±1.02 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.77 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Triglycerides (mmol/l)<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1.63 (1.34–2.24) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1.51 (1.13–2.25) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.02 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">HDL (mmol/l) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1.12±0.17 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1.10±0.22 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.36 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">LDL (mmol/l) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.68±0.70 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.77±0.67 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.24 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Uric acid (μmol/l) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">329.2±75.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">311.6±72.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.06 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Fibrinogen (μmol/l) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10.23±1.79 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">9.92±1.77 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.13 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Hemoglobin (g/dl) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13.4±1.3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">13.3±1.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.51 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">WBC (×10<span class="elsevierStyleSup">9</span>/l) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7.88±1.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">8.11±2.2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.32 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Platelet count (×10<span class="elsevierStyleSup">9</span>/l)<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">248 (190–286) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">194 (170–216) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Ejection fraction (%) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">63±5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">62±6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.34 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab982784.png" ] ] ] "notaPie" => array:1 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Median (interquartile range).</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Laboratory parameters of the study population.</p>" ] ] 4 => array:7 [ "identificador" => "tbl0030" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0115" class="elsevierStyleSimplePara elsevierViewall">Values are median (interquartile range). p values were calculated by the Mann-Whitney U test. GGT: gamma glutamyltransferase, hs-CRP: high-sensitivity C-reactive protein.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Focal ectasia (n=76) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Diffuse ectasia (n=91) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">p \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Single-vessel (n=100) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Multivessel (n=67) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">p \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">GGT (U/l) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">16 (13–20) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">42 (25–47) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.001 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">19 (15–22) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">45 (40–48) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">hs-CRP (mg/l) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.4 (1.7–3.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.1 (2.1–3.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.01 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2.4 (1.7–3.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3.2 (2.7–3.9) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab982785.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0090" class="elsevierStyleSimplePara elsevierViewall">Serum gamma glutamyltransferase and high-sensitivity C-reactive protein levels in subgroups of patients with coronary artery ectasia.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:32 [ 0 => array:3 [ "identificador" => "bib0165" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Coronary artery ectasia – is it time for reappraisal?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P. Ramappa" 1 => "A. Kottam" 2 => "H. Kuivanemi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/clc.20002" "Revista" => array:6 [ "tituloSerie" => "Clin Cardiol" "fecha" => "2007" "volumen" => "30" "paginaInicial" => "214" "paginaFinal" => "217" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17492685" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0170" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Aneurysmal coronary artery disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "P.S. Swaye" 1 => "L.D. Fisher" 2 => "P. Litwin" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "1983" "volumen" => "67" "paginaInicial" => "134" "paginaFinal" => "138" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/6847792" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0175" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Coronary artery ectasia: its prevalence and clinical significance in 4993 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G.G. Hartnell" 1 => "B.M. Parnell" 2 => "R.B. Pridie" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Br Heart J" "fecha" => "1985" "volumen" => "54" "paginaInicial" => "392" "paginaFinal" => "395" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/4052280" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0180" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inflammation in atherosclerosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "P. Libby" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nature01323" "Revista" => array:6 [ "tituloSerie" => "Nature" "fecha" => "2002" "volumen" => "420" "paginaInicial" => "868" "paginaFinal" => "874" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12490960" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0185" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Comparison of C-reactive protein levels in patients with coronary artery ectasia versus patients with obstructive coronary artery disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "H. Turhan" 1 => "A.R. Erbay" 2 => "A.S. Yasar" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2004.07.120" "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2004" "volumen" => "94" "paginaInicial" => "1303" "paginaFinal" => "1306" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15541253" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0190" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Chronic inflammatory status in patients with coronary artery ectasia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "J.J. Li" 1 => "S.P. Nie" 2 => "X.W. Qian" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.cyto.2008.12.012" "Revista" => array:6 [ "tituloSerie" => "Cytokine" "fecha" => "2009" "volumen" => "46" "paginaInicial" => "61" "paginaFinal" => "64" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19232498" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0195" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The natural history of aneurysmal coronary artery disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "V.P. Demopoulos" 1 => "C.D. Olympios" 2 => "C.N. Fakiolas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Heart" "fecha" => "1997" "volumen" => "78" "paginaInicial" => "136" "paginaFinal" => "141" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9326986" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0200" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Coronary ectasia: prevalence, and clinical and angiographic characteristics" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "E. Pinar Bermúdez" 1 => "R. López Palop" 2 => "I. Lozano Martínez-Luengas" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Esp Cardiol" "fecha" => "2003" "volumen" => "56" "paginaInicial" => "473" "paginaFinal" => "479" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12737785" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0205" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk factors and outcomes in patients with coronary artery aneurysms" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "T.S. Baman" 1 => "J.H. Cole" 2 => "C.M. Devireddy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2004.03.011" "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2004" "volumen" => "93" "paginaInicial" => "1549" "paginaFinal" => "1551" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15194034" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0210" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relation of coronary artery ectasia to diabetes mellitus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A.E. Androulakis" 1 => "G.K. Andrikopoulos" 2 => "A.N. Kartalis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2004.01.049" "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2004" "volumen" => "93" "paginaInicial" => "1165" "paginaFinal" => "1167" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15110214" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0215" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Coronary artery ectasia: clinical and angiographical evaluation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "H. Yilmaz" 1 => "N. Sayar" 2 => "M. Yilmaz" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Turk Kardiyol Dern Ars" "fecha" => "2008" "volumen" => "36" "paginaInicial" => "530" "paginaFinal" => "535" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19223718" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0220" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gamma glutamyl transferase" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.B. Whitfield" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/20014091084227" "Revista" => array:6 [ "tituloSerie" => "Crit Rev Clin Lab Sci" "fecha" => "2001" "volumen" => "38" "paginaInicial" => "263" "paginaFinal" => "355" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11563810" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0225" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gamma glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "M. Emdin" 1 => "A. Pompella" 2 => "A. Paolicchi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.105.571919" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2005" "volumen" => "112" "paginaInicial" => "2078" "paginaFinal" => "2080" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16203922" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0230" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atherosclerotic plaques contain gamma-glutamyl transpeptidase activity" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Paolicchi" 1 => "M. Emdin" 2 => "E. Ghliozeni" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/01.CIR.0000120558.41356.E6" "Revista" => array:5 [ "tituloSerie" => "Circulation" "fecha" => "2004" "volumen" => "109" "paginaInicial" => "1440" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15037540" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0235" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gamma glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults" "autores" => array:1 [ 0 => array:3 [ "colaboracion" => "Vorarlberg Health Monitoring and Promotion Program Study Group" "etal" => true "autores" => array:3 [ 0 => "E. Ruttmann" 1 => "L.J. Brant" 2 => "H. Concin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/CIRCULATIONAHA.105.552547" "Revista" => array:6 [ "tituloSerie" => "Circulation" "fecha" => "2005" "volumen" => "112" "paginaInicial" => "2130" "paginaFinal" => "2137" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16186419" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0240" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D.S. Lee" 1 => "J.C. Evans" 2 => "S.J. Robins" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1161/01.ATV.0000251993.20372.40" "Revista" => array:6 [ "tituloSerie" => "Arterioscler Thromb Vasc Biol" "fecha" => "2007" "volumen" => "27" "paginaInicial" => "127" "paginaFinal" => "133" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17095717" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0245" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D.H. Lee" 1 => "K. Silventoinen" 2 => "G. Hu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/eurheartj/ehl086" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2006" "volumen" => "27" "paginaInicial" => "2170" "paginaFinal" => "2176" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16772340" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0250" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Serum gamma-glutamyl transferase activity increased in patients with coronary artery ectasia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "N. Sen" 1 => "N. Basar" 2 => "O. Maden" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MCA.0b013e32830eaba1" "Revista" => array:6 [ "tituloSerie" => "Coron Artery Dis" "fecha" => "2008" "volumen" => "19" "paginaInicial" => "455" "paginaFinal" => "458" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18923240" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0255" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Antioxidant status and levels of antioxidant vitamins in coronary artery ectasia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "F. Koc" 1 => "N. Kalay" 2 => "I. Ardic" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MCA.0b013e328346b864" "Revista" => array:6 [ "tituloSerie" => "Coron Artery Dis" "fecha" => "2011" "volumen" => "22" "paginaInicial" => "306" "paginaFinal" => "310" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21502863" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0260" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evaluation of overall fibrinolytic activity in patients with coronary artery ectasia: global fibrinolytic capacity" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Dogan" 1 => "T. Tunc" 2 => "O. Ergene" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Int J Cardiovasc Imaging" "fecha" => "2003" "volumen" => "19" "paginaInicial" => "465" "paginaFinal" => "471" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14690185" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0265" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence of ectasia in human coronary arteries in patients in northern Greece referred for coronary angiography" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "G.D. Giannoglou" 1 => "A.P. Antoniadis" 2 => "Y.S. Chatzizisis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjcard.2006.02.034" "Revista" => array:6 [ "tituloSerie" => "Am J Cardiol" "fecha" => "2006" "volumen" => "98" "paginaInicial" => "314" "paginaFinal" => "318" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16860015" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0270" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Adaptive-outward and maladaptive-inward arterial remodeling measured by intravascular ultrasound in hyperhomocysteinemia and diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "H.K. Reddy" 1 => "S.K. Koshy" 2 => "S. Wasson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Cardiovasc Pharmacol Ther" "fecha" => "2006" "volumen" => "11" "paginaInicial" => "65" "paginaFinal" => "76" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16703221" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0275" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Coronary heart disease in patients with diabetes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "S.M. Haffner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJM200004063421408" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2000" "volumen" => "342" "paginaInicial" => "1040" "paginaFinal" => "1042" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10749967" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0280" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gamma-glutamyltransferase and prognosis in patients with stable coronary heart disease followed over 8 years" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "L.P. Breitling" 1 => "N.C. Grandi" 2 => "H. Hahmann" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.atherosclerosis.2009.12.037" "Revista" => array:6 [ "tituloSerie" => "Atherosclerosis" "fecha" => "2010" "volumen" => "210" "paginaInicial" => "649" "paginaFinal" => "655" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20092819" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0285" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Matrix metalloproteinases and inflammatory markers in coronary artery ectasia: their relationship to severity of coronary artery ectasia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Dogan" 1 => "N. Tuzun" 2 => "Y. Turker" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MCA.0b013e3283109079" "Revista" => array:6 [ "tituloSerie" => "Coron Artery Dis" "fecha" => "2008" "volumen" => "19" "paginaInicial" => "559" "paginaFinal" => "563" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19005290" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0290" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Temporal association between circulating proteolytic, inflammatory and neurohormonal markers in patients with coronary ectasia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Finkelstein" 1 => "Y. Michowitz" 2 => "A. Abashidze" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.atherosclerosis.2004.10.020" "Revista" => array:6 [ "tituloSerie" => "Atherosclerosis" "fecha" => "2005" "volumen" => "179" "paginaInicial" => "353" "paginaFinal" => "359" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15777553" "web" => "Medline" ] ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0295" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association between serum gamma glutamyltransferase and C-reactive protein" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.H. Lee" 1 => "D.R. Jacobs Jr." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.atherosclerosis.2004.08.027" "Revista" => array:6 [ "tituloSerie" => "Atherosclerosis" "fecha" => "2005" "volumen" => "178" "paginaInicial" => "327" "paginaFinal" => "330" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15694941" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0300" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "D.H. Lee" 1 => "D.R. Jacobs" 2 => "M. Gross" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Chem" "fecha" => "2003" "volumen" => "49" "paginaInicial" => "1358" "paginaFinal" => "1366" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12881453" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0305" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mean platelet volume in patients with isolated coronary artery ectasia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "A. Bitigen" 1 => "A.C. Tanalp" 2 => "O.H. Elonu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s11239-006-9028-1" "Revista" => array:6 [ "tituloSerie" => "J Thromb Thrombolysis" "fecha" => "2007" "volumen" => "24" "paginaInicial" => "99" "paginaFinal" => "103" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17243013" "web" => "Medline" ] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0310" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association between coronary artery ectasia and neutrophil-lymphocyte ratio" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "S. Balta" 1 => "S. Demirkol" 2 => "T. Celik" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0003319713480424" "Revista" => array:6 [ "tituloSerie" => "Angiology" "fecha" => "2013" "volumen" => "64" "paginaInicial" => "627" "paginaFinal" => "632" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23471489" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0315" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relation of red cell distribution width with presence and severity of coronary artery ectasia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "T. Isik" 1 => "M. Kurt" 2 => "E. Ayhan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/1076029612447678" "Revista" => array:6 [ "tituloSerie" => "Clin Appl Thromb Hemost" "fecha" => "2012" "volumen" => "18" "paginaInicial" => "441" "paginaFinal" => "447" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22619398" "web" => "Medline" ] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0320" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mean platelet volume in patients with coronary artery ectasia" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:3 [ 0 => "E. Varol" 1 => "S. Akcay" 2 => "M. Ozaydin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MBC.0b013e3283255ffa" "Revista" => array:6 [ "tituloSerie" => "Blood Coagul Fibrinolysis" "fecha" => "2009" "volumen" => "20" "paginaInicial" => "321" "paginaFinal" => "324" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19417633" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/08702551/0000003500000001/v2_201601300110/S0870255115003170/v2_201601300110/en/main.assets" "Apartado" => array:4 [ "identificador" => "358" "tipo" => "SECCION" "pt" => array:2 [ "titulo" => "Artigos originais" "idiomaDefecto" => true ] "idiomaDefecto" => "pt" ] "PDF" => "https://static.elsevier.es/multimedia/08702551/0000003500000001/v2_201601300110/S0870255115003170/v2_201601300110/en/main.pdf?idApp=UINPBA00004E&text.app=https://revportcardiol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255115003170?idApp=UINPBA00004E" ]
Ano/Mês | Html | Total | |
---|---|---|---|
2024 Novembro | 11 | 6 | 17 |
2024 Outubro | 61 | 44 | 105 |
2024 Setembro | 76 | 27 | 103 |
2024 Agosto | 72 | 39 | 111 |
2024 Julho | 50 | 36 | 86 |
2024 Junho | 54 | 25 | 79 |
2024 Maio | 66 | 29 | 95 |
2024 Abril | 53 | 33 | 86 |
2024 Maro | 58 | 25 | 83 |
2024 Fevereiro | 51 | 22 | 73 |
2024 Janeiro | 34 | 30 | 64 |
2023 Dezembro | 36 | 29 | 65 |
2023 Novembro | 44 | 28 | 72 |
2023 Outubro | 29 | 15 | 44 |
2023 Setembro | 29 | 17 | 46 |
2023 Agosto | 43 | 20 | 63 |
2023 Julho | 19 | 7 | 26 |
2023 Junho | 37 | 7 | 44 |
2023 Maio | 52 | 29 | 81 |
2023 Abril | 23 | 6 | 29 |
2023 Maro | 65 | 18 | 83 |
2023 Fevereiro | 33 | 20 | 53 |
2023 Janeiro | 26 | 10 | 36 |
2022 Dezembro | 37 | 21 | 58 |
2022 Novembro | 56 | 25 | 81 |
2022 Outubro | 38 | 16 | 54 |
2022 Setembro | 38 | 32 | 70 |
2022 Agosto | 26 | 27 | 53 |
2022 Julho | 48 | 30 | 78 |
2022 Junho | 25 | 23 | 48 |
2022 Maio | 42 | 27 | 69 |
2022 Abril | 36 | 40 | 76 |
2022 Maro | 34 | 31 | 65 |
2022 Fevereiro | 23 | 26 | 49 |
2022 Janeiro | 28 | 29 | 57 |
2021 Dezembro | 32 | 30 | 62 |
2021 Novembro | 44 | 42 | 86 |
2021 Outubro | 26 | 42 | 68 |
2021 Setembro | 24 | 26 | 50 |
2021 Agosto | 27 | 29 | 56 |
2021 Julho | 25 | 24 | 49 |
2021 Junho | 32 | 19 | 51 |
2021 Maio | 31 | 22 | 53 |
2021 Abril | 48 | 41 | 89 |
2021 Maro | 69 | 14 | 83 |
2021 Fevereiro | 43 | 12 | 55 |
2021 Janeiro | 23 | 12 | 35 |
2020 Dezembro | 27 | 9 | 36 |
2020 Novembro | 38 | 11 | 49 |
2020 Outubro | 24 | 14 | 38 |
2020 Setembro | 34 | 16 | 50 |
2020 Agosto | 30 | 14 | 44 |
2020 Julho | 53 | 14 | 67 |
2020 Junho | 37 | 18 | 55 |
2020 Maio | 34 | 5 | 39 |
2020 Abril | 40 | 11 | 51 |
2020 Maro | 42 | 12 | 54 |
2020 Fevereiro | 152 | 12 | 164 |
2020 Janeiro | 42 | 3 | 45 |
2019 Dezembro | 41 | 9 | 50 |
2019 Novembro | 48 | 9 | 57 |
2019 Outubro | 42 | 5 | 47 |
2019 Setembro | 63 | 6 | 69 |
2019 Agosto | 32 | 12 | 44 |
2019 Julho | 46 | 14 | 60 |
2019 Junho | 45 | 22 | 67 |
2019 Maio | 41 | 17 | 58 |
2019 Abril | 33 | 10 | 43 |
2019 Maro | 93 | 13 | 106 |
2019 Fevereiro | 117 | 14 | 131 |
2019 Janeiro | 95 | 4 | 99 |
2018 Dezembro | 68 | 12 | 80 |
2018 Novembro | 178 | 13 | 191 |
2018 Outubro | 468 | 13 | 481 |
2018 Setembro | 121 | 15 | 136 |
2018 Agosto | 40 | 12 | 52 |
2018 Julho | 48 | 13 | 61 |
2018 Junho | 68 | 7 | 75 |
2018 Maio | 115 | 10 | 125 |
2018 Abril | 103 | 3 | 106 |
2018 Maro | 131 | 7 | 138 |
2018 Fevereiro | 89 | 5 | 94 |
2018 Janeiro | 47 | 4 | 51 |
2017 Dezembro | 141 | 6 | 147 |
2017 Novembro | 46 | 5 | 51 |
2017 Outubro | 38 | 7 | 45 |
2017 Setembro | 64 | 6 | 70 |
2017 Agosto | 45 | 7 | 52 |
2017 Julho | 37 | 7 | 44 |
2017 Junho | 61 | 9 | 70 |
2017 Maio | 49 | 16 | 65 |
2017 Abril | 31 | 27 | 58 |
2017 Maro | 41 | 12 | 53 |
2017 Fevereiro | 35 | 9 | 44 |
2017 Janeiro | 49 | 4 | 53 |
2016 Dezembro | 33 | 12 | 45 |
2016 Novembro | 43 | 13 | 56 |
2016 Outubro | 55 | 8 | 63 |
2016 Setembro | 38 | 8 | 46 |
2016 Agosto | 14 | 5 | 19 |
2016 Julho | 12 | 10 | 22 |
2016 Junho | 7 | 11 | 18 |
2016 Maio | 4 | 15 | 19 |
2016 Abril | 40 | 2 | 42 |
2016 Maro | 50 | 20 | 70 |
2016 Fevereiro | 94 | 64 | 158 |
2016 Janeiro | 54 | 32 | 86 |